Epic Sciences: Disease Progression Diagnostics Company Epic Sciences Raises $24 Million

Epic Sciences - a privately held diagnostics company - announced it has completed a $24 million Series G which together with its $43 million Series F financing, totals $67 million raised in the last 12 months. The post Disease Progression Diagnostics Company Epic Sciences Raises $24 Million appeared first on Pulse 2.0.